Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 7 of 7 clinical reviews.
A clinician-reviewed deep dive into how East Asian pharmacogenomics, NNMT activity, CYP2C19/CYP2D6 variants, and lower BMI thresholds, shape NMN and NR efficacy, with ethnicity-stratified trial data and dosing guidance.
Read clinical reviewHispanic and Latino patients face unique pharmacogenomic and metabolic factors that may alter NMN and NR efficacy. This evidence-based review covers trial data, enzyme variants, dosing considerations, and what clinicians need to know.
Read clinical reviewA clinically detailed guide to NMN and NR dosing considerations for patients of Black and African ancestry, covering pharmacogenomics, NAD+ biology, relevant comorbidity patterns, and practical prescribing guidance.
Read clinical reviewEvidence-based guide to NMN and NR dose adjustments for East Asian patients, covering pharmacogenomic variants, BMI thresholds, NAD+ metabolism differences, and practical clinical recommendations.
Read clinical reviewEvidence-based review of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) safety profiles in East Asian populations, including pharmacogenomic variants, dosing considerations, and monitoring recommendations.
Read clinical reviewA clinical review of NMN and NR safety, pharmacogenomics, and dosing considerations specific to Black and African ancestry patients, including G6PD prevalence, NAD+ metabolism, and hypertension interactions.
Read clinical reviewA clinician-reviewed guide to NMN and NR pharmacogenomics, dosing considerations, and safety differences relevant to Hispanic and Latino patients, including CYP2E1 variants, diabetes prevalence, and ethnicity-stratified trial data.
Read clinical review